Medical Marijuana, Inc. Announces Sponsorship and Participation at 5th Annual Americans for Safe Access Unity Conference in D.C.

by adminTorusBrand | Apr 4, 2017 | Press Releases

Medical Marijuana, Inc. Representatives to Speak and Help Lobby Congress at Conference Focused on Medical Cannabis Policy and Safe Access Globally SAN DIEGO, April 4, 2017 /PRNewswire/ — Medical Marijuana, Inc. ( MJNA ), the first publicly traded cannabis...

Medical Marijuana, Inc. Joins ASA Unity Conference to Fight for Safe Access to Cannabis

by adminTorusBrand | Apr 3, 2017 | Company News

As part of our core mission to extend safe and reliable access to cannabinoids to everyone, Medical Marijuana, Inc. has signed onto the Americans for Safe Access (ASA) Unity Conference 2017 as a premier event sponsor. Additionally, several members of the Medical...

AXIM® Biotechnologies to Develop Chewing Gum with Bioequivalence to Marinol®

by adminTorusBrand | Mar 30, 2017 | Axim Biotechnologies, Company News, Scientific Research

[vc_row][vc_column][vc_column_text] AXIM® Biotechnologies, a major Medical Marijuana, Inc. investment company, has taken the first steps toward developing a chewing gum bioequivalent to Marinol, made using a synthetic version of THC or tetrahydrocannabinol. This week,...

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil To Hold Country’s First-Ever Symposium On Medical Cannabis For Health Professionals

by adminTorusBrand | Mar 30, 2017 | Company News, HempMeds Brasil, Press Releases

Company to Educate Brazilian Medical Community on Therapeutic Uses of Cannabis, Importation Rules to Provide Patients Greater Access SAN DIEGO, March 30, 2017 — Medical Marijuana, Inc. ( MJNA ), the first publicly traded cannabis company in the United States,...

Medical Marijuana, Inc. Major Investment AXIM Biotech Enters Term Sheet Agreement With U.S. API Company To Develop Bioequivalent Product To Marinol

by adminTorusBrand | Mar 28, 2017 | Axim Biotechnologies, Press Releases

[vc_row][vc_column][vc_column_text]SAN DIEGO, March 28, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech)...